Antibody Maker Loses License Over Animal Welfare Violations

The US Department of Agriculture orders Santa Cruz Biotechnology to pay a $3.5 million fine and to cease selling research antibodies.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

goatsFLICKR, DJANIMALAccording to a settlement with the US Department of Agriculture (USDA) announced late last week (May 20), Santa Cruz Biotechnology will lose its dealer’s license. The company, which has for years been accused of various animal welfare violations, will be able to sell its remaining antibody stocks, but that’s it. The firm must also pay a $3.5 million fine—an order of magnitude greater than any previous fines for violations of the federal Animal Welfare Act, BuzzFeed News reported.

The settlement follows years of allegations of the Santa Cruz Biotech’s mistreatment of the goats and rabbits it used to generate antibodies. In addition to inspectors’ reports of poor animal treatment, one veterinarian testified at a 2015 hearing that the company had a barn of 800 goats that it had kept hidden from inspectors for years.

“The current settlement includes the ‘neither admits nor denies’ language about the company’s culpability, but you don’t give up a big piece of your business and agree to the largest animal-welfare fine in USDA history if you think you have a good case,” Derek Lowe wrote on his blog.

“[The settlement] should serve as a loud and clear message to all research facilities, animal dealers, exhibitors and airlines regulated ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo